Marvin Martens
Overview
Explore the profile of Marvin Martens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yarar N, Martens M, Rognes T, Lavender J, Dirven H, Audouze K, et al.
Bioinform Adv
. 2025 Feb;
5(1):vbaf007.
PMID: 39968376
Motivation: The Adverse Outcome Pathways (AOP)-Wiki, a knowledge database for AOPs, requires an efficient way to present an overview of its content for the reconstruction of networks by experts in...
2.
Mortensen H, Amos J, Exner T, Flores K, Harper S, Jarabek A, et al.
Comput Toxicol
. 2024 Oct;
30.
PMID: 39381054
The National Nanotechnology Initiative organized a Nanoinformatics Conference in the 2023 Biden-Harris Administration's Year of Open Science, which included interested U.S. and EU stakeholders, and preceded the U.S.-EU COR meeting...
3.
van Rijn J, Martens M, Ammar A, Cimpan M, Fessard V, Hoet P, et al.
J Cheminform
. 2024 May;
16(1):49.
PMID: 38693555
Adverse Outcome Pathways (AOPs) have been proposed to facilitate mechanistic understanding of interactions of chemicals/materials with biological systems. Each AOP starts with a molecular initiating event (MIE) and possibly ends...
4.
Agrawal A, Balci H, Hanspers K, Coort S, Martens M, Slenter D, et al.
Nucleic Acids Res
. 2023 Nov;
52(D1):D679-D689.
PMID: 37941138
WikiPathways (wikipathways.org) is an open-source biological pathway database. Collaboration and open science are pivotal to the success of WikiPathways. Here we highlight the continuing efforts supporting WikiPathways, content growth and...
5.
Martens M, Stierum R, Schymanski E, Evelo C, Aalizadeh R, Aladjov H, et al.
F1000Res
. 2023 Oct;
10.
PMID: 37842337
Toxicology has been an active research field for many decades, with academic, industrial and government involvement. Modern omics and computational approaches are changing the field, from merely disease-specific observational models...
6.
Murugadoss S, Vrcek I, Schaffert A, Paparella M, Pem B, Sosnowska A, et al.
ALTEX
. 2023 Aug;
41(1):76-90.
PMID: 37606097
The adverse outcome pathway (AOP) framework plays a crucial role in the paradigm shift of toxicity testing towards the development and use of new approach methodologies. AOPs developed for chemicals...
7.
Wittwehr C, Clerbaux L, Edwards S, Angrish M, Mortensen H, Carusi A, et al.
ALTEX
. 2023 Aug;
41(1):50-56.
PMID: 37528748
Adverse outcome pathways (AOPs) provide evidence for demonstrating and assessing causality between measurable toxicological mechanisms and human or environmental adverse effects. AOPs have gained increasing attention over the past decade...
8.
Martens M, Kreidl F, Ehrhart F, Jean D, Mei M, Mortensen H, et al.
Front Oncol
. 2022 May;
12:849640.
PMID: 35558518
Malignant pleural mesothelioma (MPM) is a highly aggressive malignancy mainly triggered by exposure to asbestos and characterized by complex biology. A significant body of knowledge has been generated over the...
9.
Martens M, Evelo C, Willighagen E
Appl In Vitro Toxicol
. 2022 Apr;
8(1):2-13.
PMID: 35388368
Introduction: The AOP-Wiki is the main platform for the development and storage of adverse outcome pathways (AOPs). These AOPs describe mechanistic information about toxicodynamic processes and can be used to...
10.
Mortensen H, Martens M, Senn J, Levey T, Evelo C, Willighagen E, et al.
Front Toxicol
. 2022 Mar;
4:803983.
PMID: 35295213
Computational toxicology is central to the current transformation occurring in toxicology and chemical risk assessment. There is a need for more efficient use of existing data to characterize human toxicological...